IP Library Granted Patent US 8,426,595
Granted Patent B2
US 8,426,595 · App. 12/747,011 · Granted Apr 23, 2013

Gamma secretase modulators

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,595
App. No.
12/747,011
Granted
Apr 23, 2013
Kind
B2
Abstract

This invention provides novel compounds that are modulators of gamma secretase. The compounds have the formula [Chemical formula should be inserted here as it appears on abstract in electronic form.] Also disclosed are methods of modulating gamma secretase activity and methods of treating Alzheimer's disease using the compounds of formula (I).

Claims (13)

1. A compound of the formula:

or a pharmaceutically acceptable salt thereof,

wherein R 1 is an alkyl group substituted with one phenyl, wherein the phenyl is optionally substituted with 1-3 halo or one SF 5 group;

R 2 is hydrogen or alkyl; and

R 21 is hydrogen or halo.

2. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein the alkyl group of R 1 is methyl or ethyl.

3. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein the phenyl of R 1 is substituted with 1-3 fluoro.

4. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein R 2 is methyl.

5. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein R 21 is chloro.

6. The compound according to claim 1 or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

7. A pharmaceutical composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

8. A pharmaceutical composition comprising a compound according to claim 6 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Assignments (2)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →